Qyuns Therapeutics Co., Ltd. (HKG:2509)
Hong Kong · Delayed Price · Currency is HKD 16.30
+0.15 (0.93%)
Jul 31, 2026, 4:08 PM HKT
Qyuns Therapeutics Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Operating Activities
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 314.45 | -335.57 | -507.75 | -298.19 | -411.04 |
Depreciation & Amortization | 32.1 | 32.67 | 32.29 | 30.54 | 25.64 |
Loss (Gain) From Sale of Assets | 0.19 | - | 0.01 | - | 0.01 |
Loss (Gain) From Sale of Investments | -2.09 | -4.24 | -5.7 | -11.9 | 233.6 |
Stock-Based Compensation | 48.75 | 75.46 | 131.3 | 41.56 | 11.73 |
Other Operating Activities | -79.05 | -2.47 | -0.8 | -14.08 | -2.09 |
Change in Accounts Receivable | 14.69 | -27.44 | -6.7 | - | - |
Change in Inventory | -28.34 | -3.84 | -4.94 | - | - |
Change in Accounts Payable | 70.49 | 78.54 | 72.1 | 12.81 | 17.38 |
Change in Unearned Revenue | 34.86 | 7.85 | 0.23 | -0.64 | -0.59 |
Change in Other Net Operating Assets | -6.2 | -7.06 | -10.71 | 14.69 | 2.77 |
Operating Cash Flow | 399.85 | -186.09 | -300.68 | -225.21 | -122.58 |
Operating Cash Flow Growth | - | - | - | - | - |
Investing Activities
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Capital Expenditures | -7.48 | -1.22 | -7.87 | -20.11 | -57.98 |
Sale (Purchase) of Intangibles | -0.15 | -0.54 | -0.07 | -2.65 | -0.96 |
Investment in Securities | 117.53 | -30.79 | 246.39 | 13.18 | -195.54 |
Other Investing Activities | 8.78 | 7.33 | 4.67 | 3.88 | 7.06 |
Investing Cash Flow | 118.69 | -25.23 | 243.11 | -5.7 | -247.42 |
Financing Activities
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Long-Term Debt Issued | 269.8 | 512.33 | 113.6 | 15.9 | - |
Long-Term Debt Repaid | -218.41 | -338.73 | -66.65 | -16.55 | -3.01 |
Net Debt Issued (Repaid) | 51.39 | 173.61 | 46.95 | -0.65 | -3.01 |
Issuance of Common Stock | 90.97 | 196.54 | 29.5 | 228 | 300.07 |
Repurchase of Common Stock | -27.19 | - | - | - | - |
Other Financing Activities | -21.45 | -18.33 | -15.24 | -15.85 | -15.59 |
Financing Cash Flow | 93.73 | 351.81 | 61.21 | 211.49 | 281.48 |
Net Cash Flow
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Foreign Exchange Rate Adjustments | -11.2 | 3.89 | -0.43 | 14.46 | -2.72 |
Net Cash Flow | 601.06 | 144.39 | 3.21 | -4.97 | -91.23 |
Free Cash Flow
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 392.37 | -187.31 | -308.56 | -245.33 | -180.55 |
Free Cash Flow Growth | - | - | - | - | - |
Free Cash Flow Margin | 48.62% | -117.96% | - | -2539.08% | -845.71% |
Free Cash Flow Per Share | 1.75 | -0.85 | -1.50 | -1.38 | -1.55 |
Levered Free Cash Flow | 360.02 | -53.9 | -125.29 | -152.54 | - |
Unlevered Free Cash Flow | 372.04 | -39.28 | -114.78 | -140.86 | - |
Additional Metrics
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash Interest Paid | 19.91 | 17.52 | 14.42 | 15.49 | 15.33 |
Change in Working Capital | 85.5 | 48.06 | 49.98 | 26.86 | 19.56 |